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Abstract: Two new minor constituents, musinisins A (1) and B (2), together with five known compounds (3–7), were isolated from 
the aerial parts of Munronia sinica. Their structures were established by means of spectroscopic methods and the absolute  
stereochemistry of 1 was determined by single crystal X-ray experiment. Compound 4 showed antiangiogenic activity evaluated by 
a zebrafish model and apoptosis-inducing effect on A549 lung cancer cells. 
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Introduction 
The genus of Munronia (Meliaceae) is composed of about 
15 species in the world, and 8 species of them were distributed 
in China.1 Up to now, some phytochemical studies have been 
reported on M. delavayi2–5 and M. henryi6–9, and 
tetranortriterpenoids and triterpenoids are their main  
components. Especially, tetranortriterpenoids exhibit chemical 
defensive function in nature, such as antibacterium,  
antifungal,2 and antifeeding8 activities. M. sinica Diels grows 
in Jinfoshan of Sichuan, which is low subshrubs and an  
endemic species of China. To the date, no chemical research 
has been published about this species. In this paper, we  
reported the isolation and structure elucidation of two new 
compounds, musinisins A (1) and B (2), together with five 
known compounds, including glucoacetosyringone (3),10 6,7-
bis(acetyloxy)-4,4,8-trimethyl-3-oxo-(5α,6α,7α,13α,17α,20ξ)-
carda-1,14-dienolide (4),11 cannabiside D (5),12 corchoionoside 
C (6),13 (+)-3-oxo-α-ionyl glucoside (7).14 Compounds 1–7 
were tested for their antiangiogenic activities using a zebrafish 
model and the antiproliferative activities using A549 lung 
cancer cells. 
 
Results and Discussion 
A 70% aqueous acetone extract prepared from the leaves and stems of M. sinica was partitioned between EtOAc and 
H2O. The EtOAc layer was subjected repeatedly to column 
chromatography on silica gel, Sephadex LH-20, and RP-18, to 
afford compounds 1–7. Their structures were shown in Figure 
1, and 1H and 13C NMR spectroscopic data were listed in 
Tables 1 and 2. 
 
Figure 1.  The structures of compounds 1–7 
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Compound 1 was obtained as colorless crystals. Its 
molecular formula, C14H26O8, was established on the basis of 
HRESIMS analysis ([M – H]–, m/z 321.1543, calcd 321.1549) 
and its 1H and 13C NMR spectra. Analysis of the 1H and 13C 
NMR (Table 1), HSQC and HMBC spectra of 1 revealed the 
presence of 14 carbons, including one carboxylic acid group 
(C 175.7), one i-pr group (C 27.6, 19.4, 18.1), one methyl (C 
21.4), one methylene (C 31.3), two methines (C 44.7 and 
75.9), and one hexose (C 102.8, 76.9, 76.9, 73.9, 70.3, 61.3). 
In the 1H-1H COSY spectrum (Figure 2), the correlation of H-
2/H-3/H-4/Me-5 was observed, which established the direct 
connections of C-2, C-3, C-4 and C-5. The i-pr group locating 
at C-3 (C 44.7) was determined by the HMBC correlations of 
H-3 (H 1.87, m) with the carbon signals at C 27.6 (C-1) and 
19.4 (C-2) of i-pr group and 1H-1H COSY correlation of H-3 
with H-1 (Figure 2). The linkage position of the hexose 
moiety was located at C-4 (C 75.9) of its aglycone by the 
HMBC correlations of the anomeric proton at H 4.13 with C-4. 
The anomeric center of the sugar moiety was determined to be 
-configuration from the large 3JH1-H2 value (J = 7.8 Hz). 
Furthermore, we get a suitable crystal and the X-ray 
experiment was conducted using an anomalous dispersion with 
copper radiation (Figure 3), which not only determined the 
hexose to be D-glucose, but also established the absolute 
stereochemistry of 1. In combination with IUPAC sequence 
rule,15 the configuration of C-3 and C-4 were deduced as R and 
S, respectively. Thus, the structure of 1 was established as 
(3R,4S)-3-isopropyl-4-hydroxypentanoic acid 4-O-β-D-gluco-
pyranoside and given the name of musinisin A. The plausible 
biogenetic pathway of 1, starting from, 3-isopropyl-4-
methylcyclohexene was also discussed (Scheme 1). 
Compound 2 was isolated as yellow powder with [α]19.9D   –
54.86 (c 0.14, MeOH). The molecular formula, C16H24O9, was 
deduced by HRESIMS ([M + Cl]– at m/z 395.1100; calcd 
395.1108), with five degrees of unsaturation. The 1H NMR 
spectrum (Table 2) showed signals for two methoxyl groups. 
Comparison of the 1D and 2D NMR data of 2 with those of 
known compound glucoacetosyringone (3)10 revealed that 
compound 2 was structurally similar to 3. The differences 
were resulted from the appearance of an oxygenated methine 
signal (C 68.2, CH; H 4.6, m), and the lack of a carbonyl 
signal in 2. This indicated that the carbonyl group at C-7 in 3 
was replaced by an oxygenated methine group in 2, which was 
confirmed by the HMBC correlations of H-2 (H 6.62), H-6 
(H 6.62) and Me-8 (H 1.30) with C-7 (C 68.2) and the 1H-1H 
COSY correlation of H-7/Me-8 (Figure 2). Acid hydrolysis of 
2 (5 mg) in 2 M HCl (3 mL) provided a D-glucose and an 
aglycone (C10H14O4, an amorphous powder, [α]19.9D   –4.63). The 
glycosyl group was detected by TLC comparison with 
authentic sample using CHCl3-MeOH (8:2) as a developing 




















Figure 2.  Key HMBC (→) and 1H-1H COSY ( ) 
correlations of 1 and 2 
 
Figure 3.  X-ray structure of 1 showing absolute configuration 
Table 1. The NMR (DMSO-d6, δ in ppm, J in Hz) data of 1 
position δC δH position δC δH 
1 175.7 C  3' 18.1 CH3 0.79 (d, 6.6) 
2a 31.3 CH2 2.28 (dd, 16.2, 5.7) Glc   
2b  2.03 (dd, 16.2, 5.9) 1'' 102.8 CH 4.13 (d, 7.8) 
3 44.7 CH 1.87 (m) 2'' 73.9 CH 2.90 (t, 8.5) 
4 75.9 CH 3.77 (m) 3'' 76.9 CH 3.08 (m) 
5 21.4 CH3 1.05 (d, 6.6) 4'' 70.3 CH 3.00 (m) 
i-pr   5'' 76.9 CH 3.03 (m) 
1' 27.6 CH 1.78 (m) 6'' 61.3 CH2 3.63 (br. d, 11.3) 
2' 19.4 CH3 0.82 (d, 6.7)   3.40 (dd, 11.3, 4.4) 
 
Scheme 1.  Hypothetical biogenetic pathway of 1 
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was determined to be -configuration from the large 3JH1-H2 
value (J = 7.3 Hz). As the aglycone showed a negative optical 
rotation value that was opposite to that of (1R)-1-phenyl-1-
propanol,16 the absolute configuration at C-7 of 2 was 
suggested to be S. Thus, the structure of 2 was established and 
given the trivial name musinisin B. 
The antiangiogenic activities of compounds 1, 2, 4, 5 and 7 
were evaluated using a zebrafish model, in terms of the  
inhibition on the growth of intersegmental vessels, with 
PTK787 as positive control (IC50 0.15 g/mL).17 The results 
showed that intersegmental vessels of embryos treated with 4 
was significantly less than that of the control (0.1% DMSO in 
sterile salt water). The inhibition ratio of 4 was 58.7% at a 
concentration of 40 g/mL (Table 3). The antiproliferative 
activities of compounds 1–7 were evaluated using A549 lung 
cancer cells by MTT assay.18 The results indicated that  
compounds 1, 2, 4 and 7 showed a certain extent antiprolifera-
tive activities (Table 4). From the photos of acridine orange 
staining, compound 4 showed obvious effect of inducing apop-
tosis of A549 lung cancer cells (Figure 4). 
 
Experimental Section 
General Experimental Procedures. Melting point was  
obtained on an XRC-1 micro melting point apparatus and is 
uncorrected. Optical rotations were measured with a Jasco  
P-1020 polarimeter. UV spectra were obtained using a  
Shimadzu UV-2401A spectrophotometer. A Bruker Tenor 27 
spectrophotometer was used for scanning IR spectroscopy 
with KBr pellets. 1D and 2D NMR spectra were recorded on 
Bruker DRX-500 spectrometers. Unless otherwise specified, 
chemical shifts () were expressed in ppm with reference to 
the solvent signals. Mass spectra were performed on an API 
QSTAR Pulsar i spectrometer. Column chromatography was 
performed with silica gel (200–300 mesh, Qingdao Marine 
Chemical, Inc., Qingdao, China). Fractions were monitored by 
TLC and spots were visualized by heating silica gel plates 
sprayed with 10% H2SO4 in EtOH. 
 
Plant Material. The aerial parts of M. sinica were collected 
in Jinfoshan Mountain of Sichuan Province, China, in August 
2008. The specimen was identified by Prof. Yong-Ping Yang 
and a voucher specimen (ChenYu-200801) has been deposited 
at the Institute of Tibetan Plateau Research at Kunming,  
Kunming Institute of Botany, Chinese Academy of Sciences. 
 
Extraction and Isolation. The dried aerial parts of  
M. sinica (8.0 kg) were powdered and extracted with 70% 
aqueous Me2CO (15 L  4) for 48 hours at room temperature 
and filtrated. The filtrate was concentrated and partitioned 
with EtOAc. The EtOAc portion was subjected to column 
chromatography over MCI gel eluting with 95% EtOH and 
concentrated in vacuo. The residue (190 g) was chromato-
graphed on silica gel column eluting with CHCl3-MeOH (1:0, 
9:1, 8:2, 2:1, 1:1, and 0:1) to afford fractions I–VI.  
Fraction II (9:1) was repeatedly chromatographed on silica gel 
(200–300 mesh) and Sephadex LH-20 to yield compounds 1 
Table 2. The NMR (100 MHz, DMSO-d6, δ in ppm, J in Hz) data of 2 
position δC δH position δC δH 
1 143.2 C  Glc   
2 103.5 CH 6.62 (s) 1' 102.9 CH 4.81 (d, 7.3) 
3 152.4 C  2' 74.2 CH 3.19 (m) 
4 133.1 C  3' 76.5 CH 3.19 (m) 
5 152.4 C  4' 70.0 CH 3.15 (m) 
6 103.5 CH 6.62 (s) 5' 77.2 CH 3.02 (m) 
7 68.2 CH 4.63 (m) 6' 61.0 CH2 3.56 (dd, 11.5, 5.9) 
8 25.9 CH3 1.30 (d, 6.4)   3.42 (dd, 11.5, 5.9) 
   2  CH3O 56.4 CH3 3.72 (s) 
 
control                                            4 
Figure 4.  Photos of acridine orange staining 
Table 3. Antiangiogenic activity of compounds 1, 2, 4, 5 and 7 
compound concentration (μg/mL) intersegmental vessels (ISV) inhibition ratio (%) IC50 (μg /mL) 
1 100 17.9±3.8 26.0  
2 100 20.2±6.9 16.5  
4 40 10.0±6.6 58.7 35.7 
5 60 17.1±8.8 29.4 96.5 
7 100 22.8±2.3 5.6  
controla  24.2±2.0  
PTK787 10 0** 100  
a0.1% DMSO in sterile salt water; **means that the value was significantly different from the control and p < 0.01. 
Table 4. Inhibitory effect of compounds 1, 2, 4, and 7 on the 









aM (%) means the mean value of inhibition ratio, **p < 0.01, 
compared with control group. 
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(10 mg), 2 (15 mg), 3 (8 mg), 4 (20 mg), 5 (18 mg), 6 (18 mg), 
and 7 (13 mg). 
 
Musinisin A (1): colorless crystal; mp 150–151 C; [α]19.8D   –
23.95 (c 0.35, MeOH); IR (KBr) νmax 3490, 3347, 2985, 2901, 
1698, 1430, 1403, 1282, 1201, 1102, 1036, 1015, 939, 637 
cm–1; 1H and 13C NMR data see Table 1; negative ion ESIMS 
m/z 321 [M – H]–; HRESIMS m/z 321.1543 (calcd for 
C14H25O8 [M – H]–, 321.1549). 
 
Musinisin B (2): yellow powder; [α] 19.9D   –54.86 (c 0.14, 
MeOH); IR (KBr) max 3546, 3476, 3396, 3277, 2979, 2914, 
1598, 1462, 1425, 1327, 1130, 1068 cm–1; 1H and 13C NMR 
data see Table 2; negative ion ESIMS m/z 395 [M + Cl]–; 
HRESIMS m/z 395.1100 (calcd for C16H24O9Cl [M + Cl]–, 
395.1108). 
 
Crystallographic data for 1: C14H26O8, M = 322.36, ortho-
rhomic, space group P212121, a = 7.2561(4) Å, b = 9.5748(5) Å, 
c = 23.2846(14) Å, α =  = γ = 90, V = 1617.71(16) Å3, Z = 4, 
d = 1.373 g cm-3, crystal size 0.30 mm × 0.52 mm × 0.54 
mm, was used for measurements on a Bruker APEX DUO 
diffractometer with a graphite monochromator, Cu K radia-
tion. The total number of independent reflections  
measured was 2753, of which 2740 were observed (|F|2≥
2|F|2). Final indices: R1 = 0.0363, wR2 =0.0920 (w = 1/ |F|2). 
The crystal structure of 1 were solved and refined by the direct 
method SHELX-97 (Sheldrich, G. M. University of Gottingen: 
Gottingen, Germany, 1985). Crystallographic data for the 
structure of 1 has been deposited in the Cambridge Crystallo-
graphic Data Centre (deposition number: CCDC 853392). 
Copies of this data can be obtained free of charge via 
www.ccdc.cam.ac.uk/conts/retrieving.html (or from the Cam-
bridge Crystallographic Data Centre, 12, Union Road, Cam-
bridge CB21EZ, UK; fax: (+44) 1223-336-033; or deposit@ 
ccdc.cam.ac.uk). 
 
Acid Hydrolysis of 2. A solution of 2 (5 mg) in 2 M HCl (3 
mL) was heated in a water bath at 70 ˚C for 6 h. After cooling, 
the reaction mixture was neutralized with NaHCO3 and  
extracted with CHCl3. Through TLC comparison with authentic
sample using CHCl3-MeOH (8:2) as a developing system, D-
glucose was detected in the water layer (Rf = 0.16). The  
aqueous solution was further concentrated to dryness and  
subjected to a silica gel chromatography eluting with CHCl3-
MeOH (9:1) to give D-glucose (1 mg), [α] 18D    40 (c 0.2, 
MeOH). The CHCl3 fraction was further subjected to a silica 
gel chromatography eluting with petroleum ether-EtOAc (4:1) 
to afford the aglycone (1.2 mg), [α]19.9D   –4.63 (c 0.17, MeOH). 
 
Antiangiogenesis Bioassay. Stock solutions (10 mg/mL) of 
all samples were prepared by dissolving the test compounds in 
100% DMSO. These solutions were diluted in sterile salt  
water (5 mM NaCl, 0.17 mM KCl, 0.4 mM CaCl2, and 0.16 
mM MgSO4) to obtain solutions with the test compounds  
dissolved in 0.1% DMSO. These solutions were aliquot into 
96-well plates, and embryos at 24 hpf (hours post fertilization) 
were also transferred randomly into the above wells. After 24h 
of treatment, the intersegmental vessels of embryos were  
visualized with green fluorescent protein labeling and  
endogenous alkaline phosphatase staining. The antiangiogenic 
activities of compounds were calculated from the inhibition 
ratio of angiogenesis. PTK787 was used as the positive control. 
 
Antiproliferative Bioassay. A549 lung cancer cells were 
cultured in RPMI 1640 medium at 37 oC with 5% CO2 and 
95% air, supplemented with 10% (v/v) bovine calf serum and 
80 U/ml penicillin/streptomycin. The cells were seeded onto 
96-well plates and treated with compounds at 3, 10, 30 and 
100 g/mL for 48h, respectively. Cell viability was determined
by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium) 
assay. The light absorption was measured at 570 nm using 
Spectra MAX 190 microplate spectrophotometer (GMI Co., 
USA). Inhibition rate was calculated by the formula:  
Inhibition (%) = 100% – (OD treatment – OD blank)/(OD control – 
OD blank) × 100% 
The cells were incubated with compounds (100 g/mL) for 
48 h, and stained with 0.1 mg/ml of acridine orange (AO) at 
room temperature for 5 min. Then the cells were observed and 
photographed using the fluorescent stereo microscope  
(Olympus, Japan). 
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